Search results for the GEO ID: GSE6044
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM140166
GPL201
Adenocarcinoma A1 Primary lung cancer samples age: 62 gender: m disease: Adenocarcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140167
GPL201
Adenocarcinoma A2 Primary lung cancer samples age: 80 gender: w disease: Adenocarcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140168
GPL201
Adenocarcinoma A3 Primary lung cancer samples age: 63 gender: m disease: Adenocarcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140169
GPL201
Adenocarcinoma A4 Primary lung cancer samples age: 45 gender: w disease: Adenocarcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140170
GPL201
Adenocarcinoma A5 Primary lung cancer samples age: 62 gender: m disease: Adenocarcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140171
GPL201
Adenocarcinoma A6 Primary lung cancer samples age: 72 gender: m disease: Adenocarcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140172
GPL201
Adenocarcinoma A7 Primary lung cancer samples age: 61 gender: m disease: Adenocarcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140173
GPL201
Adenocarcinoma A8 Primary lung cancer samples age: 52 gender: m disease: Adenocarcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140174
GPL201
Adenocarcinoma A9 Primary lung cancer samples age: 59 gender: w disease: Adenocarcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140175
GPL201
Adenocarcinoma A10 Primary lung cancer samples age: 59 gender: m disease: Adenocarcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140176
GPL201
Small Cell Lung Cancer K1 Primary lung cancer samples age: 74 gender: m disease: Small Cell Lung Cancer received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140177
GPL201
Small Cell Lung Cancer K2 Primary lung cancer samples age: 74 gender: m disease: Small Cell Lung Cancer received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140178
GPL201
Small Cell Lung Cancer K3 Primary lung cancer samples age: 66 gender: w disease: Small Cell Lung Cancer received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140179
GPL201
Small Cell Lung Cancer K4 Primary lung cancer samples age: 39 gender: w disease: Small Cell Lung Cancer received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140180
GPL201
Small Cell Lung Cancer K5 Primary lung cancer samples age: 80 gender: w disease: Small Cell Lung Cancer received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140181
GPL201
Small Cell Lung Cancer K6 Primary lung cancer samples age: 64 gender: w disease: Small Cell Lung Cancer received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140182
GPL201
Small Cell Lung Cancer K7 Primary lung cancer samples age: 61 gender: m disease: Small Cell Lung Cancer received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140183
GPL201
Small Cell Lung Cancer K8 Primary lung cancer samples age: 69 gender: m disease: Small Cell Lung Cancer received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140184
GPL201
Small Cell Lung Cancer K9 Primary lung cancer samples age: 54 gender: w disease: Small Cell Lung Cancer received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140185
GPL201
Normal Lung Tissue N1 Lung samples age: 74 gender: m disease: Normal Lung Tissue received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140186
GPL201
Normal Lung Tissue N2 Lung samples age: 72 gender: m disease: Normal Lung Tissue received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140187
GPL201
Normal Lung Tissue N3 Lung samples age: 63 gender: m disease: Normal Lung Tissue received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140188
GPL201
Normal Lung Tissue N4 Lung samples age: 64 gender: w disease: Normal Lung Tissue received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140189
GPL201
Normal Lung Tissue N5 Lung samples age: 76 gender: w disease: Normal Lung Tissue received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140190
GPL201
Squamous Cell Carcinoma P1 Primary lung cancer samples age: 79 gender: m disease: Squamous Cell Carcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140191
GPL201
Squamous Cell Carcinoma P2 Primary lung cancer samples age: 75 gender: m disease: Squamous Cell Carcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140192
GPL201
Squamous Cell Carcinoma P3 Primary lung cancer samples age: 57 gender: m disease: Squamous Cell Carcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140194
GPL201
Squamous Cell Carcinoma P4 Primary lung cancer samples age: 73 gender: m disease: Squamous Cell Carcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140195
GPL201
Squamous Cell Carcinoma P5 Primary lung cancer samples age: 56 gender: m disease: Squamous Cell Carcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140196
GPL201
Squamous Cell Carcinoma P6 Primary lung cancer samples age: 69 gender: m disease: Squamous Cell Carcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140197
GPL201
Squamous Cell Carcinoma P7 Primary lung cancer samples age: 45 gender: m disease: Squamous Cell Carcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140198
GPL201
Squamous Cell Carcinoma P8 Primary lung cancer samples age: 73 gender: w disease: Squamous Cell Carcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140200
GPL201
Squamous Cell Carcinoma P9 Primary lung cancer samples age: 75 gender: m disease: Squamous Cell Cancer received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140201
GPL201
Squamous Cell Carcinoma P10 Primary lung cancer samples age: 59 gender: m disease: Squamous Cell Carcinoma received platinum-based therapy with progression: no Laser captured primary lung cancer cells
GSM140205
GPL201
Primary lung cancer therapy T1 Primary lung cancer samples age: 77 gender: m disease: received platinum-based therapy with progression: yes Laser captured primary lung cancer cells
GSM140207
GPL201
Adenocarcinoma therapy T2 Primary lung cancer samples age: 52 gender: m disease: Adenocarcinoma received platinum-based therapy with progression: yes Laser captured primary lung cancer cells
GSM140209
GPL201
Adenocarcinoma therapy T3 Primary lung cancer samples age: 62 gender: m disease: Adenocarcinoma received platinum-based therapy with progression: yes Laser captured primary lung cancer cells
GSM140211
GPL201
Primary lung cancer therapy T4 Primary lung cancer samples age: 66 gender: m disease: received platinum-based therapy with progression: yes Laser captured primary lung cancer cells
GSM140212
GPL201
Adenocarcinoma therapy T5 Primary lung cancer samples age: 48 gender: m disease: Adenocarcinoma received platinum-based therapy with progression: yes Laser captured primary lung cancer cells
GSM140214
GPL201
Adenocarcinoma therapy T6 Primary lung cancer samples age: 49 gender: w disease: Adenocarcinoma received platinum-based therapy with progression: yes Laser captured primary lung cancer cells
GSM140215
GPL201
Adenocarcinoma therapy T7 Primary lung cancer samples age: 69 gender: m disease: Adenocarcinoma received platinum-based therapy with progression: yes Laser captured primary lung cancer cells
GSM140216
GPL201
Adenocarcinoma therapy T8 Primary lung cancer samples age: 60 gender: m disease: Adenocarcinoma received platinum-based therapy with progression: yes Laser captured primary lung cancer cells
GSM140217
GPL201
Squamous Cell Carcinoma therapy T9 Primary lung cancer samples age: 74 gender: m disease: Squamous Cell Carcinoma received platinum-based therapy with progression: yes Laser captured primary lung cancer cells
GSM140218
GPL201
Squamous Cell Carcinoma therapy T10 Primary lung cancer samples age: 53 gender: m disease: Squamous Cell Carcinoma received platinum-based therapy with progression: yes Laser captured primary lung cancer cells
GSM140219
GPL201
Squamous Cell Carcinoma therapy T11 Primary lung cancer samples age: 53 gender: m disease: Squamous Cell Carcinoma received platinum-based therapy with progression: yes Laser captured primary lung cancer cells
GSM140220
GPL201
Squamous Cell Carcinoma therapy T12 Primary lung cancer samples age: 67 gender: m disease: Squamous Cell Carcinoma received platinum-based therapy with progression: yes Laser captured primary lung cancer cells
GSM140221
GPL201
Squamous Cell Carcinoma therapy T13 Primary lung cancer samples age: 58 gender: m disease: Squamous Cell Carcinoma received platinum-based therapy with progression: yes Laser captured primary lung cancer cells
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes